Metraipolis › archive › dc_4ded889eca25

The elevated expression of ORF75, a KSHV lytic gene, in Kaposi sarcoma lesions is driven by a GC-rich DNA cis element in its promoter region — Europe PMC PMID:40096169

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40096169
DOI
10.1371/journal.ppat.1012984
License (as archived)
CC0-1.0
Archived
2026-10-06T12:00:41.430Z
SHA-256 of the archived text
04f85ef5d04828bbccbb64ea4c296540d377fc1f07e42c2072debc5072bfefdb
Stable URL of this page
https://metraipolis.com/documento/dc_4ded889eca25

How to cite

The elevated expression of ORF75, a KSHV lytic gene, in Kaposi sarcoma lesions is driven by a GC-rich DNA cis element in its promoter region — Europe PMC PMID:40096169 — Europe PMC (en), https://europepmc.org/article/MED/40096169 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_4ded889eca25 (Metraipolis archive dc_4ded889eca25, sha256 04f85ef5d04828bbccbb64ea4c296540d377fc1f07e42c2072debc5072bfefdb)
BibTeX
@misc{dc4ded889eca25,
  title = {The elevated expression of ORF75, a KSHV lytic gene, in Kaposi sarcoma lesions is driven by a GC-rich DNA cis element in its promoter region — Europe PMC PMID:40096169},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40096169},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_4ded889eca25; sha256 04f85ef5d04828bbccbb64ea4c296540d377fc1f07e42c2072debc5072bfefdb},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/40096169. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

The spindle cells of Kaposi sarcoma (KS) lesions primarily express Kaposi sarcoma herpesvirus (KSHV) latent genes with minimal expression of lytic genes. However, recent transcriptome analyses of KS lesions have shown high expression of KSHV open reading frame (ORF) 75, which is considered a late lytic gene based on analyses in primary effusion lymphoma (PEL) lines. ORF75 encodes a pseudo-amidotransferase that is part of the viral tegument, acts as a suppressor of innate immunity, and is essential for viral lytic replication. We assessed a representative KS lesion by RNAscope and found that ORF75 RNA was expressed in the majority of latency-associated nuclear antigen (LANA)-expressing cells. Luciferase fusion reporter constructs of the ORF75 promoter were analyzed for factors potentially driving its expression in KS. The ORF75 promoter construct showed high basal transcriptional activity in vitro in endothelial cells, mediated by a proximal consensus specificity protein 1 (Sp1) (GGGGCGGGGC) element along with two distal CCAAT boxes. Sp proteins formed complexes with the proximal consensus Sp1 element to activate ORF75 promoter transcription. We also found evidence that a repressive factor or factors in B cells, but not endothelial or epithelial cells, interacted with more distal elements in the ORF75 promoter region to repress constitutive ORF75 expression in B cells. Alternate forms of Sp1 were found to accumulate during latency and showed substantial enrichment during viral lytic replication in PEL cells and infected endothelial cells, but their functional significance is unclear. We also found that ORF75 can in turn upregulate its own expression and that of other KSHV genes. Thus, while ORF75 acts primarily as a lytic gene in PEL cell lines, Sp proteins induce substantial constitutive ORF75 transcription in infected endothelial cells and this can account for its high expression in KS lesions.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS pathogens, 2025 (prima pubblicazione 2025-03-17).
Identificativi: PMID 40096169 · PMCID PMC11981178 · DOI 10.1371/journal.ppat.1012984.
Descrittori MeSH principali: Herpesvirus 8, Human; Sarcoma, Kaposi; Viral Proteins; Gene Expression Regulation, Viral; Promoter Regions, Genetic.
Pagina: https://europepmc.org/article/MED/40096169 — https://doi.org/10.1371/journal.ppat.1012984. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T10:21:18.030Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.